Developmental outcome of 5-year-old children born to opiate-dependent mothers: Effects of a multidisciplinary intervention during pregnancy;Devenir à 5 ans des enfants de mères dépendantes aux opiace's: effets d'un suivi multidisciplinaire pendant la grossesse

Archives de Pediatrie

Volumn 18, Issue 11, 2011, Pages 1130-1138

  Roy, J ^a   Toubin, R M ^a   Mazurier, E ^b   Chanal, C ^b   Misraoui, M ^b   Brulet, C ^b   Molenat, F ^a  

^a Montpellier 1 University   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; GROWTH RETARDATION; HOSPITAL DISCHARGE; HUMAN; MATERNAL CARE; MOTHER CHILD RELATION; OBESITY; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRENATAL EXPOSURE; PRESCHOOL CHILD; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; SOCIAL CARE; CHILD WELFARE; FEMALE; MALE; PATIENT CARE; PREGNANCY; PREGNANCY COMPLICATION;

CHILD; CHILD DEVELOPMENT; CHILD WELFARE; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MOTHER-CHILD RELATIONS; OPIOID-RELATED DISORDERS; PATIENT CARE TEAM; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 80055102229     PISSN: 0929693X     EISSN: 1769664X     Source Type: Journal    
DOI: 10.1016/j.arcped.2011.08.014     Document Type: Article

References (30)

1. Minozzi S, Amato L, Vecchi S, et al. Maintenance agonist treatments for opiate-dependent pregnant women. Cochrane Database Syst Rev 2008: CD006318.
2. Thaitumyanon P., Limpongsanurak, Praisuwanna P., et al. Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant. S J Med Assoc Thai 2005, 88:1506-1513.
3. Ciraru-Vigneron N., Rafowicz E., Nguyen-Tan Lung R., et al. Toxicomanie et grossesse: principales conséquences obstétricales et pédiatriques. J Gyn Obst Biol Reprod 1989, 18:637-648.
4. Winklbaur B., Jung E., Fisher G. Opioid dependence and pregnancy. Curr Opin Psychiatry 2008, 21:255-259.
5. Lejeune C. Conséquences périnatales des addictions durant la grossesse. Arch Pediatr 2007, 14:656-658.
6. Tronick E., Beeghly M. Prenatal cocaine exposure, child development, and the compromising effects of cumulative risk. Clin Perinatol 1999, 26:151-171.
7. Tyler R., Howard J., Espinosa M., et al. Placement with substance-abusing mothers vs. placement with other relatives: infant outcomes. Child Abuse Negl 1997, 21:337-349.
8. Lejeune C., Ropert J.C., Montamat S., et al. Devenir médico-social de 59 nouveaux-nés de mère toxicomane. J Gyn Obst Biol Reprod 1997, 26:395-404.
9. MacMahon J.R. Perinatal substance abuse: the impact of reporting infants to child protective services. Pediatrics 1997, 100:E1.
10. Frank D.A., Jacobs R.R., Beeghly M., et al. Level of prenatal cocaine exposure and scores on the bayley scales of infant development: modifying effects of caregiver, early intervention, and birth weight. Pediatrics 2002, 110:1143-1152.
11. Eriksson M., Jonsson B., Steneroth G., et al. Amphetamine abuse during pregnancy: environmental factors and outcome after 14-15years. Scand J Public Health 2000, 28:154-157.
12. Moe V. Foster placed and adopted children exposed in utero to opiates and other substances: prediction and outcome at four and a half years. J Dev Behav Pediatr 2002, 23:330-339.
13. Nair P., Black M.M., Ackerman J.P., et al. Children's cognitive-behavioral functioning at age 6 and 7: prenatal drug exposure and caregiving environment. Ambul Pediatr 2008, 8:154-162.
14. Ornoy A., Segal J., Bar-Hamburger R., et al. Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors. Dev Med Child Neurol 2001, 43:668-675.
15. Mazurrier E., Chanal C., Misraoui M., et al. De la femme à l'enfant: les liens interpersonnels autour de la femme enceinte sous opiacés. Arch Pediatr 2000, 7(2):281-282.
16. Brulet C., Chanal C., Ravel P., et al. Un suivi multidisciplinaire et un soutien psychosocial diminuent les complications de la dépendance aux opiacés chez les femmes enceintes 114 grossesses suivies en 5ans. Presse Med 2007, 36:1571-1580.
17. Frankenburg W.K., Dodds J.B. The denver developmental screening test. J Pediatr 1967, 71:181-191.
18. Goyettte C.H., Conners C.K., Ulrich R.F. Normative data on revised Conners parent and teacher rating scales. J Abnorm Child Psychol 1978, 6:221-236.
19. World health organization international statistical classification of diseases and related health problems. 10th revision version for 2007.
20. Mises R., Quemada N., Botbol M., et al. Classification française des troubles mentaux de l'enfant et de l'adolescent. Psychopathology 2002, 35:176-180.
21. Desmartin-Belarbi V, Ledesert B, Boulahtouf H. ORS Languedoc Roussillon: recherche-action sur le développement des enfants scolarisés dans deux groupes scolaires; rapport d'étude janvier 2002.
22. Pascal J., Lombrail P., Agard C. Identification de la vulnérabilité sociale des usagers des consultations de l'hôpital public. Presse Med 2004, 11:710-715.
23. Lowenstein W., Gourarier L., Coppel A., et al. La méthadone et les traitements de substitution collection conduites 1995, Doin Edition, Paris.
24. Morrison J.L., Duffield J.A., Muhlhausler D., et al. Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity. Pediatr Nephrol 2010, 25:669-677.
25. Ebert J. Maternité interactions mère-enfant et toxicomanie 2001, OFDT, Paris, [p. 112].
26. Rees C.A. Thinking about children's attachments. Arch Dis Child 2005, 90:1058-1065.
27. Ackermann J.P., Llorente A.M., Black M.M., et al. The effect of prenatal drug exposure and caregiving context on children's performance on a task of sustained visual attention. J Dev Behav Pediatr 2008, 29:467-474.
28. Du Mazaubrun C., Garel M., Ancel P.Y., et al. Difficultés du suivi d'une cohorte d'enfants nés grands prématurés: EPIPAGE Paris petite couronne. Arch Pediatr 2006, 13:1202-1208.
29. Sharpe-Stimac M., Wang Y., Druschel C.M., et al. Follow-up survey of parents of children with major birth defects in New York state. Birth Def Res A Clin Teratol 2004, 70:597-602.
30. Bunikowski R., Grimmer I., Heiser A., et al. Neurodevelopmental outcome after prenatal exposure to opiates. Eur J Pediatr 1998, 157:724-730.